Interleukin-18 and miR-130a in severe sepsis patients with thrombocytopenia

Yao-Li Cui1, Bing Wang2, Hong-Mei Gao2

  • 1Department of Lymphoma and Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, People's Republic of China; Department of Intensive Care Unit and Key Lab for Critical Care Medicine of the Ministry of Health, Emergency Medicine Research Institute, Tianjin First Center Hospital, Tianjin, People's Republic of China.

Related Concept Videos